📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial (2021)

First Author: Butler C

Attributed to: Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00461-x

PubMed Identifier: 33676597

Publication URI: http://europepmc.org/abstract/MED/33676597

Type: Journal Article/Review

Parent Publication: The Lancet

Issue: 10279

ISSN: 0140-6736